Adage Capital Management
Adage Capital is a Boston-based hedge fund founded by Phillip Gross which held nearly $24 billion in securities at the end of the quarter ended September 30, 2010.
The firm focuses on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation.
The firm focuses on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation.
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G/A IMMUNIC, INC. Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G/A VERU INC. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SCHEDULE 13G/A Sable Offshore Corp. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SCHEDULE 13G/A Nkarta, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SCHEDULE 13G/A Syros Pharmaceuticals, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SCHEDULE 13G/A Compass Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SCHEDULE 13G/A TScan Therapeutics, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SCHEDULE 13G Karyopharm Therapeutics Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G/A enGene Holdings Inc. Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G/A EyePoint Pharmaceuticals Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G/A UroGen Pharma Ltd. Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G Dynamix Corp Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G ZEVRA THERAPEUTICS, INC. Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G/A Shattuck Labs, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SCHEDULE 13G Aclaris Therapeutics, Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G Seadrill Ltd Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G Protara Therapeutics, Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G Sitio Royalties Corp. Filed by: Adage Capital Management, L.P.
-
Form SCHEDULE 13G Janux Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
-
Tectonic Therapeutic (TECX) Announces $185M Private Placement
-
Tectonic Announces $185 Million Private Placement
-
Form D/A Adage Capital Partners,
-
ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
-
The Crown Publishing Group partners with Storehouse In A Box to launch Storehouse Voices™, a new imprint committed to elevating Black voices
-
Monopar Therapeutics (MNPR) Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
-
Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
-
Trevi Therapeutics (TRVI) Prices 12.5M Share Offering at $4/sh
-
Trevi Therapeutics Announces Pricing of $50 Million Underwritten Offering
-
Olema Pharmaceuticals (OLMA) Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement
-
Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement
-
OneGoal Selected for New York Times Communities Fund Annual Holiday Giving Campaign
-
Cidara Therapeutics (CDTX) Announces $105 Million Private Placement
-
Cidara Therapeutics Announces $105 Million Private Placement
-
Form SC 13G Zeo Energy Corp. Filed by: Adage Capital Management, L.P.
-
Aclaris Therapeutics (ACRS) Announces 35.56M Share Offering at $2.25/sh
-
Aclaris Therapeutics Announces $80 Million Private Placement
-
Form 13F-NT Adage Capital Management For: Sep 30
-
Form 13F-HR ADAGE CAPITAL PARTNERS For: Sep 30
-
Form SC 13G/A Solid Biosciences Inc. Filed by: Adage Capital Management, L.P.
-
Form SC 13G/A MeiraGTx Holdings plc Filed by: Adage Capital Management, L.P.
-
Form SC 13G/A Perella Weinberg Partner Filed by: Adage Capital Management, L.P.
-
Form SC 13G/A Corbus Pharmaceuticals Filed by: Adage Capital Management, L.P.
-
Form SC 13G/A Annexon, Inc. Filed by: Adage Capital Management, L.P.
-
Form SC 13G/A Cabaletta Bio, Inc. Filed by: Adage Capital Management, L.P.
-
Form SC 13G/A SUTRO BIOPHARMA, INC. Filed by: Adage Capital Management, L.P.

